Our finding confirms a recent analysis of 5942 individuals with CRC or unexplained polyposis that showed no evidence of an increased risk of CRC in monoallelic NTHL1 loss of function variant carriers and the absence of SBS30 mutational signature unique to biallelic inactivation of NTHL1.9 The gene discussed is NTHL1; the disease is polyposis.